Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib Cream in Adults with Atopic Dermatitis
NCT03011892Phase 2Completed
- Sponsor
- Incyte
- Start
- Jan 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ruxolitinib cream in atopic dermatitis (AD), sponsored by Incyte. Started Jan 2017; status: completed.
02
Drugs
ruxolitinib cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03011892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03011892.